Compatibilità
Salva(0)
At Cleon Capital, we are proud to support companies like Labomar that are redefining innovation in the nutraceutical industry.
This week, Labomar unveiled a €10 million three-year investment plan in Research & Development, alongside the announcement of Mucowall, its 19th patent and a major leap in pharmaceutical delivery technology.
🔬 Innovation isn’t just a goal – it’s Labomar’s engine for growth, differentiation, and value creation.
Cleon Capital
